The US Wound Care Management Devices Market is Segmented by Product (Wound Care [Dressings, Wound-Care Devices, and More] and Wound Closure [Sutures, Surgical Staplers, and More]), Wound Type (Chronic Wounds and Acute Wounds), End User (Hospitals & Specialty Wound Clinics and More), and Mode of Purchase (Institutional Procurement and Retail / OTC Channel). The Market and Forecasts are Provided in Terms of Value (USD).

US Wound Care Market size is estimated to reach USD 13.31 Billion by 2035, at a CAGR of 3.8% during the projected period

Snapshot img

Wound Care Market Size 2024-2028

The wound care market size is forecast to increase by USD 6.95 billion at a CAGR of 5.8% between 2023 and 2028.

The market is experiencing significant growth, driven primarily by the increasing prevalence of acute and chronic wounds worldwide. Chronic wounds, such as diabetic ulcers and pressure ulcers, are on the rise due to aging populations and rising incidences of diabetes and obesity. This trend is particularly prominent in developed markets, including the US, where an aging population and rising healthcare costs are major contributing factors. Another key trend in the market is the increasing demand for combination wound dressings, which offer advanced healing properties and can reduce the need for multiple products. These dressings are gaining popularity due to their ability to provide both antimicrobial and moisture-retentive properties, promoting faster wound healing. However, the high cost of wound treatments and advanced wound care products poses a significant challenge to market growth. The high cost of these products, coupled with the lengthy reimbursement process, can limit access to care for many patients. This creates an opportunity for companies to develop cost-effective solutions that offer comparable efficacy to more expensive options. Additionally, there is a growing need for innovative business models that can help reduce the overall cost of care and improve patient outcomes. Companies that can successfully navigate these challenges and offer cost-effective, effective wound care solutions are well-positioned to capitalize on the growing demand for wound care products and services.

What will be the Size of the Wound Care Market during the forecast period?

Request Free SampleThe market encompasses a diverse range of advanced products and solutions designed to promote wound healing and manage various types of wounds. This market is driven by the increasing prevalence of chronic diseases, such as diabetes, which often result in non-healing wounds, as well as the high costs associated with surgical procedures and medical expenditures. The market is witnessing significant growth due to the development and adoption of biological skin substitutes, hydrocolloid dressings, and other advanced wound care solutions. These innovative products offer benefits like moisture retention, infection prevention, and improved patient comfort. The market also caters to acute and traumatic wounds, surgical site infections, burn injuries, and traumatic injuries. Factors like healthcare education, sedentary lifestyle, and the rise of ambulatory surgical centers are further fueling market expansion. Despite these opportunities, the high costs of advanced wound care solutions remain a challenge for both healthcare providers and patients.

How is this Wound Care Industry segmented?

The wound care industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductAdvanced wound dressingsSurgical wound careTraditional wound careApplicationChronic woundAcute woundEnd UserHospitalsSpecialty ClinicsHome Care SettingsHospitalsSpecialty ClinicsHome Care SettingsDistribution ChannelInstitutional SalesRetail SalesInstitutional SalesRetail SalesGeographyNorth AmericaUSCanadaEuropeFranceGermanyItalyUKAsiaRest of World (ROW)

By Product Insights

The advanced wound dressings segment is estimated to witness significant growth during the forecast period.Advanced wound care is a critical segment of the healthcare industry, focusing on the treatment of complex wounds through the use of advanced dressings. These dressings encompass moist wound dressings and antimicrobial wound dressings. The advanced wound dressings segment holds a significant market share due to the rising prevalence of chronic wounds and burn injuries, an aging population, increasing awareness of clinical benefits, and the growing number of surgical procedures. Additionally, the adoption of advanced wound dressings in hospitals and specialized clinics, as well as new product launches, contribute to market growth. However, intense competition among companies, high costs, and limited product differentiation leading to price wars pose challenges to the market's expansion. Key factors driving the advanced the market include the increasing burden of chronic wounds, financial impact due to medical expenditures, and the prevalence of conditions like diabetes and cardiovascular ailments. Advanced wound care solutions include negative pressure therapy, bioactive wound care, and combination wound dressings for diabetic foot ulcers, venous leg ulcers, pressure ulcers, surgical wounds, and burn wounds. Technological advancements in wound care include smart dressings, tissue-engineered products, digital w

The U.S. Chronic Wound Care Market size was valued at USD 4.16 USD Billion in 2023 and is projected to reach USD 6.59 USD Billion by 2032, exhibiting a CAGR of 6.8 % during the forecast period. The U. S. chronic wound market presents persistent wounds like diabetic foot ulcers and pressure ulcers. It may provide med-tech solutions such as dressings, growth factors, and NPWT (Negative Pressure Wound Therapy). The following are used to facilitate recovery, avoid infections, and handle exudate. The trend in the market includes bioengineered skin substitutes and smart wound care technologies that allow real-time monitoring. An older population as well as the rise of chronic conditions such as, for instance, diabetes is increasing the necessity for appropriate wound care options. The market keeps changing in line with these discoveries in biotechnology and materials science, which are aimed at accelerating healing and making patient life better. Key drivers for this market are: Rising Prevalence of Brain Cancer Cases to Propel Market Growth. Potential restraints include: Rising Recalls of Wound Care Products to Limit the Market Growth. Notable trends are: Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

As per the latest Fact.MR industry analysis, rising prevalence of chronic wound disorders across the globe is set push the valuation of the advanced wound care market from US$ 11.66 billion in 2024 to US$ 16.12 billion by 2034. The market has been projected to register a CAGR of 3.3% through 2034.

Report Attributes	Details
Advanced Wound Care Market Size (2024E)	US$ 11.66 Billion
Forecasted Market Value (2034F)	US$ 16.12 Billion
Global Market Growth Rate (2024 to 2034)	3.3% CAGR
South Korea Market Value (2024E)	US$ 444.9 Million
Antimicrobial Powder Demand Growth Rate (2024 to 2034)	4% CAGR
Key Companies Profiled	Integra LifeSciences B. Braun Melsungen AG Johnson and Johnson Mölnlycke Health Care Coloplast A/S Medline Industries Inc. 3M Smith & Nephew PLC

Country-wise Analysis

Attribute	United States
Market Value (2024E)	US$ 3.5 Billion
Growth Rate (2024 to 2034)	3% CAGR
Projected Value (2034F)	US$ 4.68 Billion

Attribute	India
Market Value (2024E)	US$ 646.2 Million
Growth Rate (2024 to 2034)	5.7% CAGR
Projected Value (2034F)	US$ 1.12 Billion

Category-wise Analysis

Attribute	Antimicrobial Gels
Segment Value (2024E)	US$ 1.64 Billion
Growth Rate (2024 to 2034)	4% CAGR
Projected Value (2034F)	US$ 2.45 Billion

Attribute	Hospitals
Segment Value (2024E)	US$ 6.24 Billion
Growth Rate (2024 to 2034)	2.8% CAGR
Projected Value (2034F)	US$ 8.24 Billion

The U.S. Wound Care Centers Market size was valued at USD 9.2 billion in 2023 and is projected to reach USD 13.03 billion by 2032, exhibiting a CAGR of 5.10 % during the forecasts period. The US wound care centres market refers to facilities that offer both surgical and medical care exclusively to patients with chronic and complicated wounds. These centers perform relatively specialized services such as state of the art wound management, operative debridement and hyperbaric oxygen therapy and individually tailored programs. Market is growing largely due to the rising incidence of chronic ailments, growing geriatric populace and developments in wound care products. Some of the trends include use of modern aged care goods in the region particularly the advanced wound care products, increased utilization of digital healthcare tools for telemonitoring of patients and; shift from single professional practice to an integrated approach to patient care. Also, there is new focus on increasing the patient involvement in the treatment course, and on developing new treatments for accelerating the healing.

The global Advance Wound Care Market are expected to be approximately USD 12,385.4 million in 2025 and is likely to expand up to approximately USD 17,302.8 million by the end of 2035. The sales are believed to rise with a CAGR of 3.4 % during the period of 2025 to 2035. Advanced wound care produced revenue worth approximately USD 11,944.2 million in 2024.

Metric	Value
Industry Size (2025E)	USD 12,385.4 million
Industry Value (2035F)	USD 17,302.8 million
CAGR (2025 to 2035)	3.4%

Country Wise Analysis

Country	CAGR (2025 to 2035)
United States	1.9%

Country	CAGR (2025 to 2035)
China	6.5%

Country	CAGR (2025 to 2035)
India	7.0%

Country	CAGR (2025 to 2035)
Brazil	4.9%

The U.S. Wound Care Market size was valued at USD 6.14 USD billion in 2023 and is projected to reach USD 9.42 USD billion by 2032, exhibiting a CAGR of 6.3 % during the forecast period. Advanced wound care refers to usage of innovative techniques materials and healing procedures geared toward selling improved and effective recovery of complex wounds those superior strategies embody a range functions which include biocompatibility to ensure compatibility with the frame, moisture control skills for optimizing the wound environment high exudate absorption capacities incorporation of antimicrobial sellers to save you infections and help for granulation tissue formation important for healing those techniques are designed for smooth software and elimination to reduce trauma the impact of superior wound care includes faster restoration times decreased infection dangers more advantageous patient comfort minimized scarring fee effectiveness thru reduced headaches and progressed normal great of life for sufferers coping with challenging wound recovery scenarios Key drivers for this market are: Increasing Prevalence of Chronic Diseases and Introduction of Innovative Devices to Drive the Demand for C-arms . Potential restraints include: Recent Product Recalls to Limit the Market Growth. Notable trends are: Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

US Wound Care Management Devices Market size was valued at USD 8.1 Billion in 2024 and is projected to reach USD 15.0 Billion by 2032, growing at a CAGR of 8% from 2026 to 2032.

Aging Population and Increased Healthcare: The aging population and increased healthcare needs will drive the U.S. wound care management devices market. By 2030, every baby boomer will be 65 or older, increasing the population's susceptibility to chronic wounds and complex healing. The 65+ population is estimated to reach 74.1 million by 2030, a 22% rise from 2020, resulting in increased demand for specialized wound care solutions. This generational transition, together with advances in wound care technologies, will fuel innovation and market expansion in the coming years. Increasing Chronic Wound Prevalence: The increasing prevalence of chronic wounds will have a substantial impact on the wound care management devices industry in the United States.

The North America Advanced Wound Care Market size was valued at USD 5.1 billion in 2023 and is projected to reach USD 7.03 billion by 2032, exhibiting a CAGR of 4.7 % during the forecasts period. The North America advanced wound care market is witnessing significant growth, driven by the increasing prevalence of chronic wounds, diabetic ulcers, and surgical wounds. Technological advancements, such as the development of bioactive wound care products and negative pressure wound therapy (NPWT), are enhancing treatment outcomes. This growth is driven by factors such as: Recent developments include: In January 2023, Convatec launched the ConvaFoam in the U.S., which is a family of advanced foam dressings designed to meet the demands of medical professionals and their patients. This helped the company strengthen its presence in the U.S. market. , In July 2023, Coloplast announced the acquisition of Kerecis. This acquisition would help Coloplast expand its wound care offerings. , In January 2022, Coloplast announced the acquisition of Triad Life Sciences. This acquisition enhanced Convatec's position in advanced wound care in the U.S. and granted it access to a unique and complementary technological platform that improves patient outcomes and helps provide advanced wound treatment. .

The US wound care management devices market, a significant segment of the global healthcare industry, is experiencing steady growth fueled by an aging population, increasing prevalence of chronic diseases like diabetes and obesity leading to higher incidence of chronic wounds, and advancements in wound care technologies. The market is characterized by a diverse range of products, including wound dressings, wound closure devices (sutures, staples, adhesives), and topical agents. The chronic wound segment, encompassing diabetic foot ulcers, pressure ulcers, and venous ulcers, dominates market share due to the long-term care requirements and associated higher costs. Acute wound management, encompassing surgical wounds and burns, also contributes significantly, driven by the increasing number of surgical procedures and burn injuries. Key players like Medtronic, 3M, Smith & Nephew, and Johnson & Johnson hold substantial market share, leveraging their established distribution networks and strong brand recognition. Competition is intense, with companies focusing on innovation, particularly in advanced wound dressings (e.g., those incorporating growth factors or antimicrobial agents) and minimally invasive wound closure techniques. The market's growth is projected to remain stable, albeit with a moderate CAGR, reflecting the ongoing need for effective wound care solutions and ongoing technological advancements. However, factors such as high healthcare costs and reimbursement challenges present potential restraints to market expansion. Future growth will likely be driven by increased adoption of advanced wound care technologies, particularly in the home healthcare setting, and expanding access to specialized wound care services in underserved areas. The market is segmented geographically, with North America representing a significant portion of the overall market share due to factors such as high healthcare expenditure, advanced healthcare infrastructure, and strong presence of key market players. Growth in other regions like Asia Pacific is expected to be driven by rising healthcare awareness, increasing disposable incomes, and improving healthcare infrastructure. Europe also represents a substantial market, influenced by similar factors although at a potentially slower growth rate compared to the Asia Pacific region. Overall, the US wound care management devices market presents a robust and dynamic landscape, characterized by a blend of established players and emerging technologies, poised for continued growth driven by both demographic shifts and technological advancements in wound care. Recent developments include: April 2023: 3M Health Care's innovative 3M Veraflo Therapy, with both 3M Veraflo Cleanse Choice Complete Dressing and 3M™ V.A.C. Veraflo Cleanse Choice Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridements required, while promoting granulation tissue formation, creating an environment that promotes wound healing., January 2023: Convatec launched the ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients in the United States. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.. Key drivers for this market are: Increasing Incidences of Chronic Wounds, Ulcers and Diabetic Ulcers, Increase in the Number of Surgical Procedures; Rising Aging Population. Potential restraints include: Increasing Incidences of Chronic Wounds, Ulcers and Diabetic Ulcers, Increase in the Number of Surgical Procedures; Rising Aging Population. Notable trends are: Sutures Segment is Expected to Grow Significantly Over the Forecast Period.

The market offers a diverse range of dressings, categorized by their material and properties: foam, silicone, hydrocolloid, and hydrogel dressings each cater to specific wound types and healing stages. Beyond dressings, the market encompasses a variety of devices and accessories that significantly impact wound management. Negative pressure wound therapy (NPWT) systems accelerate healing, while advanced debridement devices efficiently remove necrotic tissue. Furthermore, sophisticated wound assessment tools enable precise monitoring and optimized treatment strategies, contributing to improved patient outcomes and reduced healthcare costs. Recent developments include: July 2023: With an upfront cash payment of USD 1.2 billion, Coloplast has agreed to pay up to USD 1.3 billion for the acquisition of Kerecis, a creative and quickly expanding firm in the biologics wound care space. Entering the high-growth, US-centric biologics sector through Kerecis offers Coloplast a strategic opportunity to strengthen its position in the advanced wound care market., January 2022: Convatec Group acquired Triad Life Sciences Inc. to get entry into the lucrative wound biologics market. Convatec's Advanced Wound Care division in the US is anticipated to benefit from this, as their highly complementary product portfolios and business acumen will improve the company.. Notable trends are: Rising prevalence of acute and chronic wounds will boost the market growth.

Recent trends in Wound Care Product Manufacturing in the US reflect a dynamic industry responding to evolving healthcare needs. Over the past few years, the sector has seen steady growth driven by increasing demand for advanced wound care solutions. Factors such as an aging population and rising incidences of chronic diseases like diabetes have bolstered this demand. Technological advancements, including innovative materials and telemedicine integration, have propelled the industry forward, enhancing treatment outcomes and patient care management. Consequently, industry revenue has been growing at a CAGR of 0.9% over the past five years and is expected to total $2.8 billion in 2024, when revenue will climb by an estimated 0.1%. Looking back over the past five years, the industry has undergone significant transformations. Market consolidation has been a notable trend, with larger companies acquiring smaller companies to broaden their product portfolios and expand their market presence. This consolidation has also fostered collaboration and accelerated innovation in wound care technologies. Also, regulatory shifts towards value-based care and patient-centric outcomes have influenced product development strategies, emphasizing the importance of efficacy and cost-effectiveness in wound management solutions. The outlook for Wound Care Product Manufacturing in the US appears promising yet challenging. Anticipated trends include continued innovation in advanced wound care products driven by ongoing research and development efforts. Integration of artificial intelligence and data analytics into wound care management is expected to enhance personalized treatment plans and improve predictive analytics for patient outcomes. Moreover, with increasing healthcare digitization and emphasis on remote patient monitoring, telehealth applications in wound care are likely to expand, offering new avenues for growth and efficiency in care delivery. However, the industry must also navigate regulatory changes, reimbursement policies and global economic factors that could impact market dynamics and profitability in the coming years. Overall, industry revenue is forecast to expand at a CAGR of 3.3% over the five years through 2029 to total $3.3 billion.

The size of the Advanced Wound Care Market in North America market was valued at USD 5.34 Million in 2023 and is projected to reach USD 6.79 Million by 2032, with an expected CAGR of 3.50% during the forecast period. The North America advanced wound care market is concerned with the care of complicated, chronic, and non-healing wounds – such as diabetic ulcers, pressure ulcers, and post-surgical complications. It includes topical solutions, sophisticated dressings, wound management devices, and accident biologics that cut the time to healing and minimize infections’ probability in the wound. Main uses are in hospitals, repute care centres, and home care services. Major factors affecting the market include a growing incidence of diseases, change in the population’s demography, and a rise in the number of surgical operations. Contemporary trends focus on products such as the bioengineered skin substitutes, growth factors, and antimicrobial dressing. Similarly, increasing innovations in the wound healing devices including negative pressure wound therapy (NPWT) are also driving the market. Recent developments include: In October 2022, Wounds Canada and the Registered Nurses Association of Ontario (RNAO) planned to launch the Wound Care Champion Program (WCCP), designed to deliver evidence-informed, interdisciplinary, proficient-level wound education for front-line clinicians. The program will train regulated health professionals in Ontario, with 200 spots to be funded by the provincial Ministry of Health., In September 2022, Arch Therapeutics, Inc., a developer of novel self-assembling wound care and bio-surgical products, launched a multi-site clinical study to accelerate payor adoption and differentiate the benefits of the AC5 Advanced Wound System in treating challenging wounds. The Study launch completes the near-term commitments listed in the Company's recently announced reimbursement initiative to accelerate sales opportunities for AC5 in doctor's offices and wound care clinics.. Key drivers for this market are: Increase in the Geriatric Population, Rising Incidences of Chronic Wound. Potential restraints include: High-cost and Risk associated with Advanced Products. Notable trends are: Suture Sub-segment by Wound Closure Segment is Expected to Grow Over the Forecast Period.

The total global advanced wound care market was valued at some 8.9 billion U.S. dollars in 2018. It is forecasted that by 2024 the market will increase to over 11 billion U.S. dollars.

The Active Wound Care Market Report is Segmented by Product (Biomaterials, Skin Substitutes, and Growth Factors), End User (Hospitals, Clinics, and Home Healthcare), Application (Chronic Wounds and Acute Wounds), and Geography (North America, Europe, Asia-Pacific, The Middle East and Africa, and South America). The Report Offers the Market Sizes in Value Terms (USD) for all the Above-Mentioned Segments.

The U.S. Advanced Wound Care Marketsize was valued at USD 4.22 USD Billion in 2023 and is projected to reach USD 6.18 USD Billion by 2032, exhibiting a CAGR of 5.6 % during the forecast period. Advanced wound care refers to the usage of innovative techniques materials and healing procedures geared toward selling improved and effective recovery of complex wounds those superior strategies embody a range of functions which include biocompatibility to ensure compatibility with the frame, moisture control skills for optimizing the wound environment high exudate absorption capacities incorporation of antimicrobial sellers to save you infections and help for granulation tissue formation important for healing those techniques are designed for smooth software and elimination to reduce trauma the impact of superior wound care includes faster restoration times decreased infection dangers more advantageous patient comfort minimized scarring fee effectiveness thru reduced headaches and progressed normal great of life for sufferers coping with challenging wound recovery scenarios Key drivers for this market are: Increasing Adoption of Synthetic BVF to Boost Market Growth. Potential restraints include: Increase in Product Recalls to Hamper the Market Growth. Notable trends are: Increasing Number of Hospitals and ASCs Identified as Significant Market Trend.

The global market for chronic wound care is forecasted to attain USD 18,675.3 million by 2025, expanding at 3.8% CAGR to reach USD 27,076.5 million by 2035. In 2024, the revenue of chronic wound care was around USD 17,941.7 million.

Metric	Value
Industry Size (2025E)	USD 18,675.3 million
Industry Value (2035F)	USD 27,076.5 million
CAGR (2025 to 2035)	3.8%

Country-wise Insights

Country	CAGR (2025 to 2035)
United States	1.2%

Country	CAGR (2025 to 2035)
Germany	1.1%

Country	CAGR (2025 to 2035)
India	9.1%

Country	CAGR (2025 to 2035)
Japan	4.8%

Country	CAGR (2025 to 2035)
Brazil	5.7%

Competitive Outlook

Company Name	Estimated Market Share (%)
Smith & Nephew	11.1%
3M	6.9%
Mölnlycke Health Care	6.7%
ConvaTec Group PLC	6.3%
Coloplast Corp.	4.2%
Others (Combining all)	64.7%

The Latin America advanced wound care market was valued at USD 816.30 Million in 2024, driven by the improving healthcare access, accelerating the development of hospitals and primary healthcare centres across the region. The market is anticipated to grow at a CAGR of 4.00% during the forecast period of 2025-2034 to achieve a value of USD 1208.32 Million by 2034.

The size of the US Wound Care Management Devices Industry market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 3.39% during the forecast period.The US Wound Care Management Devices market is diversified and comprises various types of medical technologies that help in treating acute and chronic wounds. A number of devices used for wound management have been found to accomplish their intended functions for wound healing while reducing the possibility of infection, thereby improving patient outcomes. Wound care management devices range from advanced dressings, negative pressure wound therapy systems to antimicrobial wound care products and all the way to specialized wound care devices for specific types of wounds such as diabetic ulcers and pressure ulcers. These devices apply in such healthcare settings as hospitals, clinics, and home care settings. Wound care management devices are applied for several reasons. They help ensure perfect wound healing conditions by regulating wound exudates, preventing infection, and stimulating tissue regeneration. For example, removal of wound fluids in a system for NPWT reduces edema and stimulates blood circulation in order to ensure faster healing. Advanced dressings may offer moisture balance, prevent infection in the wound, and stimulate cell growth. Antimicrobial wound care products may reduce bacterial bioburden and subsequently lower the risk of infection. With these devices, health professionals should be able to effectively deal with a wide variety of wounds, complicated or slow-to-heal, thus better patient outcome, decreased healthcare cost, and improving quality of life in people living with chronic wounds. Recent developments include: April 2023: 3M Health Care's innovative 3M Veraflo Therapy, with both 3M Veraflo Cleanse Choice Complete Dressing and 3M™ V.A.C. Veraflo Cleanse Choice Dressing, received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridements required, while promoting granulation tissue formation, creating an environment that promotes wound healing., January 2023: Convatec launched the ConvaFoam, a family of advanced foam dressings designed to address the needs of healthcare providers and their patients in the United States. ConvaFoam can be used on a spectrum of wound types at any stage of the wound journey, making it the simple dressing choice for wound management and skin protection.. Key drivers for this market are: Increasing Incidences of Chronic Wounds, Ulcers and Diabetic Ulcers, Increase in the Number of Surgical Procedures; Rising Aging Population. Potential restraints include: Concerns with Stringent Regulations and Reimbursement Policies, High Treatment Costs. Notable trends are: Sutures Segment is Expected to Grow Significantly Over the Forecast Period.